The Tumor Suppressor Smad4 Is Required for Transforming Growth Factor B-Induced Epithelial to Mesenchymal Transition and Bone Metastasis of Breast Cancer Cells (original) (raw)

The Tumor Suppressor Smad4 Is Required for Transforming Growth Factor β–Induced Epithelial to Mesenchymal Transition and Bone Metastasis of Breast Cancer Cells

Clemens Lowik

Cancer Research, 2006

View PDFchevron_right

The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells

Jeroen Buijs

Cancer research, 2006

View PDFchevron_right

Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion

Carl-henrik Heldin

Oncogene, 2013

View PDFchevron_right

Smad4-expression is decreased in breast cancer tissues: a retrospective study

Jürgen Dippon

BMC cancer, 2006

View PDFchevron_right

Smad4-Independent TGF-β Signaling in Tumor Cell Migration

Andre Menke

Cells Tissues Organs, 2007

View PDFchevron_right

Definition of smad3 phosphorylation events that affect malignant and metastatic behaviors in breast cancer cells

eunjin BAE

Cancer research, 2014

View PDFchevron_right

Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway

Inna Serganova

Proceedings of the National Academy of Sciences, 2005

View PDFchevron_right

Smad3 is a key nonredundant mediator of transforming growth factor beta signaling in Nme mouse mammary epithelial cells

Silvia Cazzola

Molecular Cancer Research, 2009

View PDFchevron_right

Activation of Canonical BMP4-SMAD7 Signaling Suppresses Breast Cancer Metastasis

Robin Anderson

Cancer Research, 2020

View PDFchevron_right

The Dual Role of Smad7 in the Control of Cancer Growth and Metastasis

Veronica De Simone

International Journal of Molecular Sciences, 2013

View PDFchevron_right

Evidence That Smad2 Is a Tumor Suppressor Implicated in the Control of Cellular Invasion

M. Mareel

Journal of Biological Chemistry, 1999

View PDFchevron_right

Reversible Smad-Dependent Signaling between Tumor Suppression and Oncogenesis

Miki Murata

View PDFchevron_right

Attenuation of Smad2 activity shows resistance to TGF-β signalling in mammary adenocarcinoma (MCF-7) cells

Suman Sengupta

Cell Biology International, 2013

View PDFchevron_right

Stable Overexpression of Smad7 in Human Melanoma Cells Impairs Bone Metastasis

Khalid Mohammad

Cancer Research, 2007

View PDFchevron_right

LMO4 can interact with Smad proteins and modulate transforming growth factor-β signaling in epithelial cells

Xiaoli Xu

Oncogene, 2006

View PDFchevron_right

Overexpression of Smad7 Blocks Primary Tumor Growth and Lung Metastasis Development in Osteosarcoma

Marie-cécile Le Deley

Clinical Cancer Research, 2014

View PDFchevron_right

Transforming Growth Factor-β1, Transforming Growth Factor-β2, and Transforming Growth Factor-β3 Enhance Ovarian Cancer Metastatic Potential by Inducing a Smad3-Dependent Epithelial-to-Mesenchymal Transition

Thúy Vy

Molecular Cancer Research, 2008

View PDFchevron_right

TGF-b signaling, Smads, and tumor suppressors

Richard W Padgett

View PDFchevron_right

Transforming growth factor-β1 suppresses bone morphogenetic protein-2/Smad signaling in human oral squamous cell carcinoma cell HSC-4 by downregulation of Smad1/9 expression

Masaharu Kamo

The Molecular Biology Society of Japan, 2016

View PDFchevron_right

Differential effect of the expression of TGF-β pathway inhibitors, Smad-7 and Ski, on invasive breast carcinomas: relation to biologic behavior

Christina Magkou

Apmis, 2011

View PDFchevron_right

Effect of Smad7 Expression on Metastasis of Mouse Mammary Carcinoma JygMC(A) Cells

Teruo Inamoto

JNCI: Journal of the National Cancer Institute, 2005

View PDFchevron_right

Evidence for a Role of Smad3 and Smad2 in Stabilization of the Tumor-derived Mutant Smad2.Q407R

Céline Prunier

Journal of Biological Chemistry, 2003

View PDFchevron_right

Breast cancer metastasis suppressor OTUD1 deubiquitinates SMAD7

Camila Ramirez

Nature communications, 2017

View PDFchevron_right

TGF- and the Smad Signaling Pathway Support Transcriptomic Reprogramming during Epithelial-Mesenchymal Cell Transition

Carl-henrik Heldin

Molecular Biology of The Cell, 2005

View PDFchevron_right

SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells

Paddy Tighe

Oncotarget, 2016

View PDFchevron_right

Signaling of transforming growth factor-β family members through Smad proteins

Marie-Jose Goumans

European Journal of Biochemistry, 2000

View PDFchevron_right

Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression

Masaharu Kamo

Oncology Reports, 2016

View PDFchevron_right

Smad4 Regulates Claudin-1 Expression in a Transforming Growth Factor-B-Independent Manner in Colon Cancer Cells

Amar Datta

2007

View PDFchevron_right

Regulation of TGF-β signaling by Smad7

Xiaohua Yan

Acta Biochimica et Biophysica Sinica

View PDFchevron_right

Homozygous deletion of SMAD4 in breast cancer cell lines and invasive ductal carcinomas

Aziza Nassar

Cancer Biology & Therapy, 2006

View PDFchevron_right

A SNAIL1–SMAD3/4 transcriptional repressor complex promotes TGF-β mediated epithelial–mesenchymal transition

Jill Johnson

Nature Cell Biology, 2009

View PDFchevron_right

Breast cancer anti-estrogen resistance 3 inhibits transforming growth factor β/Smad signaling and associates with favorable breast cancer disease outcomes

Jimin Guo, Charles Rajadurai

Breast Cancer Research, 2014

View PDFchevron_right